Treatment‐related risk factors for inhibitor development in non‐severe hemophilia A after 50 cumulative exposure days: A case‐control study

BACKGROUND: Non‐severe hemophilia A patients have a life‐long inhibitor risk. Yet, no studies have analyzed risk factors for inhibitor development after 50 factor VIII (FVIII) exposure days (EDs). OBJECTIVES: This case‐control study investigated treatment‐related risk factors for inhibitor developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdi, Amal, Eckhardt, Corien L., van Velzen, Alice S., Vuong, Caroline, Coppens, Michiel, Castaman, Giancarlo, Hart, Dan P., Hermans, Cedric, Laros‐van Gorkom, Britta, Leebeek, Frank W. G., Mancuso, Maria Elisa, Mazzucconi, Maria G., McRae, Simon, Oldenburg, Johannes, Male, Christoph, van der Bom, Johanna G., Fijnvandraat, Karin, Gouw, Samantha C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
HAEMOSTASIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457239/
https://www.ncbi.nlm.nih.gov/pubmed/34107158
http://dx.doi.org/10.1111/jth.15419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457239/
https://www.ncbi.nlm.nih.gov/pubmed/34107158
http://dx.doi.org/10.1111/jth.15419

Ejemplares similares